## Abstract ## Purpose To determine sequence parameters that maximize vascular contrast‐to‐noise (CNR) for ultra‐high resolution equilibrium phase (EP) peripheral imaging for the blood pool agent (BPA) Vasovist. ## Materials and Methods A model for maximizing CNR in EP MR angiography (MRA) is pr
High-resolution magnetic resonance angiography in the mouse using a nanoparticle blood-pool contrast agent
✍ Scribed by Gabriel P. Howles; Ketan B. Ghaghada; Yi Qi; Srinivasan Mukundan Jr.; G. Allan Johnson
- Book ID
- 102532317
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 473 KB
- Volume
- 62
- Category
- Article
- ISSN
- 0740-3194
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
High‐resolution magnetic resonance angiography is already a useful tool for studying mouse models of human disease. Magnetic resonance angiography in the mouse is typically performed using time‐of‐flight contrast. In this work, a new long‐circulating blood‐pool contrast agent—a liposomal nanoparticle with surface‐conjugated gadolinium (SC‐Gd liposomes)—was evaluated for use in mouse neurovascular magnetic resonance angiography. A total of 12 mice were imaged. Scan parameters were optimized for both time‐of‐flight and SC‐Gd contrast. Compared to time‐of‐flight contrast, SC‐Gd liposomes (0.08 mmol/kg) enabled improved small‐vessel contrast‐to‐noise ratio, larger field of view, shorter scan time, and imaging of venous structures. For a limited field of view, time‐of‐flight and SC‐Gd were not significantly different; however, SC‐Gd provided better contrast‐to‐noise ratio when the field of view encompassed the whole brain (P < 0.001) or the whole neurovascular axis (P < 0.001). SC‐Gd allowed acquisition of high‐resolution magnetic resonance angiography (52 × 52 × 100 micrometer^3^ or 0.27 nL), with 123% higher (P < 0.001) contrast‐to‐noise ratio in comparable scan time (∼45 min). Alternatively, SC‐Gd liposomes could be used to acquire high‐resolution magnetic resonance angiography (0.27 nL) with 32% higher contrast‐to‐noise ratio (P < 0.001) in 75% shorter scan time (12 min). Magn Reson Med, 2009. © 2009 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract ## Purpose To evaluate the feasibility of first‐pass contrast‐enhanced magnetic resonance angiography (MRA) using ferumoxytol in humans. ## Materials and Methods First‐pass and equilibrium phase MRA were performed using ferumoxytol in one healthy volunteer and 11 patients with a fast
FP-MRA, thereby simplifying MRA assessment of the heart and thoracic vasculature.
## Abstract ## Purpose To evaluate the combined use of carbon dioxide (CO~2~) and a gadolinium‐based blood‐pool agent for magnetic resonance angiography (MRA). ## Materials and Methods After an initial intravenous injection of the blood‐pool agent Gadomer (Schering AG, Germany), repeated transca
Gitsioudis et al.: IRON magnetic resonance: a robust technique for angiography providing high blood-to-tissue contrast within the clinically approved dosage of superparamagnetic nanoparticles.